Germline polymorphisms provide strong prognostic information in intermediate risk acute myeloblastic leukemia (AML)

被引：0

作者：

Urbano-Ispizua, A ^{[1
]}

Brunet, S ^{[1
]}

Monzo, M ^{[1
]}

Perea, G ^{[1
]}

Navarro, A ^{[1
]}

Esteve, J ^{[1
]}

Berlanga, J ^{[1
]}

Ribera, JM ^{[1
]}

Bueno, J ^{[1
]}

Llorente, A ^{[1
]}

Besalduch, J ^{[1
]}

Guardia, R ^{[1
]}

Tormo, M ^{[1
]}

Pedro, C ^{[1
]}

Sanchez, JM ^{[1
]}

Torres, P ^{[1
]}

de Llano, MPQ ^{[1
]}

Font, L ^{[1
]}

Moraleda, JM ^{[1
]}

Marti, JM ^{[1
]}

Vivancos, P ^{[1
]}

Peñarubia, MJ ^{[1
]}

Nomdedeu, J ^{[1
]}

Montserrat, E ^{[1
]}

Sierra, J ^{[1
]}

机构：

[1] CETLAM Grp, Hematol, Barcelona, Spain

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

10.1182/blood.V104.11.398.398

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

398

引用

页码：117A / 117A

页数：1

共 50 条

[21] PROGNOSTIC VALUE OF IMMUNOLOGICAL MARKERS IN ACUTE MYELOBLASTIC-LEUKEMIA
MIGUEL, JFS
OJEDA, E
GONZALEZ, M
ORFAO, A
CANIZO, MC
SANCHEZ, J
LOPEZBORRASCA, A
LEUKEMIA, 1989, 3 (02) : 108 - 111
[22] Karyotype in acute myeloblastic leukemia (AML): Prognostic significance in bone marrow transplantation in first remission (CR1).
Gorin, NC
Labopin, M
Frassoni, F
Prentice, HG
Cahn, JY
Reiffers, J
Boogaerts, M
Bandini, G
Lowenberg, B
Attal, M
Ferrant, A
EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 545 - 545
[23] MOLECULAR CHARACTERIZATION OF CELLULAR MODELS OF ACUTE MYELOBLASTIC LEUKEMIA (AML) BY MASS SEQUENCING
Boluda Navarro, M.
Ibanez, M.
Such, E.
De Matteo, B.
Neef, A.
Llop, M.
Sargas, C.
Liquori, A.
Gonzalez, E.
San Juan Pla, A.
Cervera, M.
Barragan, E.
Sanz, M. A.
Sanz, G.
Cervera, J.
HAEMATOLOGICA, 2017, 102 : 172 - 172
[24] Limits for intensifying induction therapy in younger patients with acute myeloblastic leukemia (AML)
Taksin, AL
Thomas, X
Castaigne, S
Rousselot, P
Degos, L
Archimbaud, E
Dombret, H
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 223 - 223
[25] PROLIFERATIVE STATE OF BLAST CELL PROGENITORS IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
MINDEN, MD
TILL, JE
MCCULLOCH, EA
BLOOD, 1978, 52 (03) : 592 - 600
[26] PROPOSED MOLECULAR CLASSIFICATION OF ACUTE MYELOBLASTIC LEUKEMIA (AML) BASED ON SPLICING EVENTS
Liquori, A.
Gonzalez-Saiz, E.
Fernandez-Blanco, B.
Gonzalez-Romero, E.
Avetisyan, G.
Morote-Faubel, M.
Santiago-Balsera, M.
Boluda-Navarro, M.
Sargas Simarro, C.
Martinez-Valiente, C.
Garcia-Ruiz, C.
Sanjuan-Pla, A.
Such Taboada, E.
Barragan Gonzalez, E.
Llop Garcia, M.
Montesinos Fernandez, P.
Sanz Santillana, G.
De la Rubia, J.
Cervera Zamora, J.
HAEMATOLOGICA, 2021, 106 (10) : 81 - 82
[27] MYC AMPLIFICATION AND PRESENCE OF MICRONUCLEI IN TWO PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA (AML)
Junyent, L. Puig
Montse, M.
Ranera, L.
Gomez, J. C.
Lemes, A.
Martinez, J. V.
Alvarez, Y.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 678 - 678
[28] Clinical and economic outcomes of initial acute myeloblastic leukemia (AML) hospitalization in the elderly
Nuyts, G
Janagap, C
Zilberberg, M
Piech, CT
VALUE IN HEALTH, 2006, 9 (03) : A109 - A109
[29] CONSOLIDATION TREATMENT WITH CHEMOTHERAPY REGIME VERSUS AUTOLOGOUS TRANSPLANTATION IN ACUTE MYELOBLASTIC LEUKEMIA OF LOW AND INTERMEDIATE RISK
Diaz-Aizpun, C.
Lopez-Jaime, F. J.
Barrios Garcia, M.
Contento Gonzalo, A.
Alcala Pena, M. M.
Cuesta Casas, M. A.
Martin-Tellez, S.
Doblas-Marquez, A.
Munoz-Lopez, F. D.
Munoz Perez, M., I
HAEMATOLOGICA, 2019, 104 : 424 - 425
[30] INVITRO DIFFERENTIATION AND PROLIFERATION OF MYELOID CELLS IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
GRUNWALD, HW
EXPERIMENTAL HEMATOLOGY, 1979, 7 : 72 - 72

← 1 2 3 4 5 →